Telephone-Based Weight Loss Intervention Successful in Breast Cancer Survivors
Results of the Breast Cancer Weight Loss trial were presented at the 2023 ASCO Annual Meeting.
Diagnosis & Disease Information
Switching ET and Adding Ribociclib Improves PFS in HR+, HER2- Breast Cancer
Patients with HR+, HER2- metastatic breast cancer whose disease progressed on endocrine therapy (ET) and a CDK4/6 inhibitor have better progression-free survival if they switch ET and receive ribociclib than if they switch ET alone, a phase 2 study suggests.
Extended Antibiotic Prophylaxis Not Beneficial After Postmastectomy Breast Reconstruction
Extended antibiotics do not reduce infection or reconstruction failure after postmastectomy breast reconstruction.
Testing for ESR1 Mutations Recommended in HR+, HER2- Metastatic Breast Cancer
Routine testing for ESR1 mutations should occur upon recurrence or progression of HR+, HER2- metastatic breast cancer, a guideline suggests.
Cancer Death Rates Vary Across Congressional Districts
Cancer death rates in the US have declined in recent years, but the declines vary by congressional district, a study suggests.
Postmastectomy Care Management and the Potential for Burnout During Reconstruction
This review of the options and challenges facing patients with breast cancer reviews the complications that increase patients’ risk for reconstructive burnout.
USPSTF Recommends Biennial Screening Mammography From Ages 40 to 74
In draft recommendation, task force says evidence is insufficient for assessing benefits and harms of mammography for those aged 75 years and older, women with dense breasts.
Screening Recommendations Updated for Increased Breast Cancer Risk
Women with higher-than-average breast cancer risk, especially Black and Ashkenazi Jewish women, should start screening at younger age.
Permissive Cardiotoxicity Strategy Improves Completion of Trastuzumab Cycles in HER2-Positive Breast Cancer
Researchers sought to determine if a cardiotoxicity management strategy could allow women with HER2-positive breast cancer to complete trastuzumab therapy.
Food Deserts, Swamps Linked to Increased Risk of Death From Obesity-Related Cancers
US counties with food deserts or food swamps tend to have higher rates of death from obesity-related cancers, a study suggests.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...